RIPE-KG · Version 1.1.0 · Resource

ripekg:integrity-assessment-hypothesis/RIPEA4F5D57083F3F36E5-human-1-1

https://w3id.org/ripe/ripe-kg/integrity-assessment-hypothesis/RIPEA4F5D57083F3F36E5-human-1-1
SubjectPredicateObject
ripekg:integrity-assessment-hypothesis/RIPEA4F5D57083F3F36E5-human-1-1 rdf:type rdfs:Resource
ripekg:integrity-assessment-hypothesis/RIPEA4F5D57083F3F36E5-human-1-1 rdf:type owl:Thing
ripekg:integrity-assessment-hypothesis/RIPEA4F5D57083F3F36E5-human-1-1 rdf:type ripe:IntegrityAssessmentHypothesisIntegrity assessment hypothesis
ripekg:integrity-assessment-hypothesis/RIPEA4F5D57083F3F36E5-human-1-1 rdf:type tido:Hypothesis
ripekg:integrity-assessment-hypothesis/RIPEA4F5D57083F3F36E5-human-1-1 prov:wasAttributedTo ripekg:human-reviewer/RV008
ripekg:integrity-assessment-hypothesis/RIPEA4F5D57083F3F36E5-human-1-1 prov:wasGeneratedBy ripekg:evaluation/RIPEA4F5D57083F3F36E5
ripekg:integrity-assessment-hypothesis/RIPEA4F5D57083F3F36E5-human-1-1 prov:wasMemberOf ripekg:research-integrity-assessment/RIPEA4F5D57083F3F36E5
ripekg:integrity-assessment-hypothesis/RIPEA4F5D57083F3F36E5-human-1-1 ripe:resultOutcome yes
ripekg:integrity-assessment-hypothesis/RIPEA4F5D57083F3F36E5-human-1-1 tido:answers ripekg:integrity-assessment-question/retraction-status/1.0.01.1. Does the study have an associated retraction?
ripekg:integrity-assessment-hypothesis/RIPEA4F5D57083F3F36E5-human-1-1 tido:answers ripekg:integrity-assessment-question/retraction-status/1.0.0retraction status
ripekg:publication-details/RIPEA4F5D57083F3F36E5RETRACTED ARTICLE: Magnesium-Zinc-Calcium-Vitamin D Co-supplementation Improves Hormonal Profiles, Biomarkers of Inflammation and Oxidative Stress in Women with Polycystic Ovary Syndrome: a Randomized, Double-Blind, Placebo-Controlled Trial tido:supports ripekg:integrity-assessment-hypothesis/RIPEA4F5D57083F3F36E5-human-1-1
ripekg:retraction-notice/40898Magnesium-Zinc-Calcium-Vitamin D Co-supplementation Improves Hormonal Profiles, Biomarkers of Inflammation and Oxidative Stress in Women with Polycystic Ovary Syndrome: a Randomized, Double-Blind, Placebo-Controlled Trial tido:supports ripekg:integrity-assessment-hypothesis/RIPEA4F5D57083F3F36E5-human-1-1